Gallo, Baby Boy -.

HRN: 27-51-54  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/25/2025
08/01/2025
IV
48mg
Q24H
PROM X 20hours
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Bloodstream    Compliance to guidelines: